BCLAF1 Antikörper
Kurzübersicht für BCLAF1 Antikörper (ABIN127331)
Target
Alle BCLAF1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- The antibody recognizes the BTF.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- Synthetic peptide of human BTF
-
-
-
-
Applikationshinweise
-
Western Blot: 1: 500-1: 2000. Immunoprecipitation.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS containing 30 % glycerol, 1 % BSA and 0.02 % thimerosal
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- -20 °C/-80 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at -20 °C or for long term storage (in aliquots) at -70 °C.
-
-
- BCLAF1 (BCL2-Associated Transcription Factor 1 (BCLAF1))
-
Andere Bezeichnung
- BCLAF1 / BTF
-
Hintergrund
- BTF is a transcriptional repressor that interacts with several members of the BCL2 family of proteins. Overexpression of this protein induces apoptosis, which can be suppressed by co-expression of BCL2 proteins. BTF localizes to dot-like structures throughout the nucleus, and redistributes to a zone near the nuclear envelope in cells undergoing apoptosis. Multiple transcript variants encoding different isoforms have been found for this protein.Synonyms: Aa2-041, Bcl-2-associated transcription factor 1, KIAA0164
-
Gen-ID
- 9774
-
NCBI Accession
- NP_001070908
-
UniProt
- Q9NYF8
-
Pathways
- Positive Regulation of Response to DNA Damage Stimulus
Target
-